Quest Diagnostics Incorporated (
) will begin trading ex-dividend on March 28, 2013. A cash dividend
payment of $0.3 per share is scheduled to be paid on April 16,
2013. Shareholders who purchased DGX stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
76.47% increase over the same period a year ago. At the current
stock price of $57.25, the dividend yield is 2.1%.
The previous trading day's last sale of DGX was $57.25,
representing a -11.75% decrease from the 52 week high of $64.87 and
a 7.51% increase over the 52 week low of $53.25.
DGX is a part of the Health Care sector, which includes
companies such as UnitedHealth Group Incorporated (
) and WellPoint Inc. (
). DGX's current earnings per share, an indicator of a company's
profitability, is $3.45. Zacks Investment Research reports DGX's
forecasted earnings growth in 2013 as 1.31%, compared to an
industry average of -7.2%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to DGX through an Exchange
Traded Fund [ETF]?
The following ETF(s) have DGX as a top-10 holding:
- iShares Dow Jones U.S. Health Care Providers Index (
- Vanguard Mid-Cap Value ETF (
The top-performing ETF of this group is VOE with an increase of
13.61% over the last 100 days. IHF has the highest percent
weighting of DGX at 3.47%.